Particle.news

Download on the App Store

California Confirms First NB.1.8.1 Infections as FDA Restricts COVID-19 Shot Access

Citing uncertain benefits of repeat boosters for low-risk people, the FDA limited vaccinations to adults 65 and older in preparation for a projected summer surge.

Image

Overview

  • Stanford researchers identified California’s first confirmed case of the NB.1.8.1 Omicron variant, tracing its presence in the state back to mid-April.
  • Health experts say NB.1.8.1 spreads more rapidly than earlier strains but causes symptoms comparable in severity to previous Omicron lineages.
  • FDA officials disclosed on May 27 that uncertain gains from additional doses among healthy individuals prompted a policy shift to vaccinate only seniors and those at high risk.
  • The policy change follows the Trump administration’s termination of over $700 million in COVID-19 response grants, which weakened public health infrastructure in California.
  • Public health authorities anticipate a typical summer rise in cases and are monitoring NB.1.8.1’s impact on hospitalizations and resource demands.